Sign in

CIK 0001878313

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
  1. 4 Open-market buy Director bought 40,849 shares at $1.22 ($49,999)
  2. 4 Open-market buy Director bought 81,699 shares at $1.22 ($100,000)
  3. 4 Open-market buy Director bought 13,740 shares at an average $1.20 ($16,441)
  4. 4/A Open-market buy Chief Executive Officer bought 10,500 shares at $0.97 ($10,144)
  5. 4/A Open-market buy Chief Executive Officer bought 72,000 shares at an average $1.11 ($79,849)
  6. 4 Open-market buy Chief Executive Officer bought 72,000 shares at an average $1.11 ($79,849)
  7. 4 Open-market buy Director bought 38,145 shares at an average $1.10 ($41,846)
  8. 4 Open-market buy Director bought 15,000 shares at $1.04 ($15,582)
  9. 4 Open-market buy Director bought 10,000 shares at $0.98 ($9,785)
  10. 4 Open-market buy Chief Executive Officer bought 10,500 shares at $0.97 ($10,144)
  11. 4 Open-market buy Director bought 25,000 shares at an average $0.98 ($24,600)
  12. 4 Open-market buy Chief Executive Officer bought 11,800 shares at an average $0.98 ($11,547)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Director bought 19,230 shares at $1.30 ($24,999)
  20. 4 Derivatives Options or other derivatives

Page 3 of 13 · 248 filings